Urine-Based Test Provides Accurate Testing Option for Advanced Prostate Cancer

TUESDAY, Feb. 11, 2025-- The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly sensitive for grade group (GG) ≥2 prostate cancer and can improve the proportion of biopsies avoided, a...